Chromatin architectural protein CTCF regulates gene expression of the UGT1 cluster
Received date: 2019-03-15
Revised date: 2019-04-08
Online published: 2019-05-27
Supported by
Supported by the National Natural Science Foundation of China(81872944);Supported by the National Natural Science Foundation of China(31470820);Supported by the National Natural Science Foundation of China(81302861)
UDP-glucuronosyltransferases (UGTs) are an important family of phase Ⅱ drug-metabolizing enzymes that catalyze the glucuronidation of numerous endogenous or exogenous small compounds. The aberrant expression of UGT isoforms causes many diseases, such as hyperbilirubinemia and affect drug efficacy or toxicity. Understanding mechanisms of UGT gene regulation will provide scientific foundations for disease prevention and personalized or precision medicine. Vertebrate UGT family genes can be divided into UGT1 and UGT2 subfamilies. Similar to the protocadherin, immunoglobulin, and T-cell receptor gene clusters and different from the UGT2 gene cluster, the UGT1 gene cluster is organized into variable and constant regions. The UGT1 variable region contains a tandem array of variable exons, each of which can be alternatively spliced to a single set of 4 downstream constant exons, generating at least nine UGT1 mRNAs that could be translated into different UGT1 glucuronyltransferase isoforms. Our previous work reveals that the relative orientations and locations of CTCF binding sites play a key role in the three-dimensional organization of the mammalian genomes in cell nuclei. Thus in order to study the transcriptional mechanisms of UGT1 gene cluster, the distributions and orientations of CTCF binding sites (CBSs) are analyzed and compared between human and mouse UGT1 gene clusters. We find that the CBSs in the UGT1 gene cluster are not conserved between human and mouse species. We show that CTCF and cohesin regulate the transcription of the UGT1 gene cluster by knocking down the CTCF or the cohesin subunit SMC3 in the human A549 cell line. By using CRISPR DNA-fragment editing, we deleted and inverted hCBS1. By RNA-seq experiments, we find that hCBS1 deletion results in a significant decrease of levels of the UGT1A6, UGT1A7, and UGT1A9 gene expression and that hCBS1 inversion results in a significant decrease of levels of the UGT1A7 gene expression. Our data suggest that the CTCF binding site hCBS1 plays an important regulatory role in the regulation of UGT1 gene expression, providing an experimental basis for further mechanistic studies of the 3D genome regulation of the UGT1 gene cluster.
Key words: UGT1; CTCF; CRISPR-Cas9; DNA fragment editing; transcriptional regulation
Xiaofei Zheng,Haiyan Huang,Qiang Wu . Chromatin architectural protein CTCF regulates gene expression of the UGT1 cluster[J]. Hereditas(Beijing), 2019 , 41(6) : 509 -523 . DOI: 10.16288/j.yczz.19-072
| [1] | Zhang T, Haws P, Wu Q . Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res, 2004,14(1):79-89. | |||
| [2] | Huang H, Wu Q . Cloning and comparative analyses of the zebrafish Ugt repertoire reveal its evolutionary diversity. PLoS One, 2010,5(2):e9144. | |||
| [3] | Li C, Wu Q . Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes. BMC Evol Biol, 2007,7:69. | |||
| [4] | Nagar S, Blanchard RL . Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab Rev, 2006,38(3):393-409. | |||
| [5] | Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW . Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom, 2005,15(10):677-685. | |||
| [6] | Yang N, Sun R, Liao X, Aa J, Wang G . UDP-glucuronosyltransferases (UGTs) and their related metabolic cross- talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine. Pharmacol Res, 2017,121:169-183. | |||
| [7] | Rowland A, Miners JO, Mackenzie PI . The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell B, 2013,45(6):1121-1132. | |||
| [8] | Wu Q, Zhang T, Cheng JF, Kim Y, Grimwood J, Schmutz J, Dickson M, Noonan JP, Zhang MQ, Myers RM, Maniatis T . Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. Genome Res, 2001,11(3):389-404. | |||
| [9] | Tukey RH, Strassburg CP . Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol, 2000,40:581-616. | |||
| [10] | Heath H, de Almeida CR, Sleutels F, Dingjan G, van de Nobelen S, Jonkers I, Ling KW, Gribnau J, Renkawitz R, Grosveld F, Hendriks RW, Galjart N . CTCF regulates cell cycle progression of alphabeta T cells in the thymus. EMBO J, 2008,27(21):2839-2850. | |||
| [11] | de Wit E, Vos ES, Holwerda SJ, Valdes-Quezada C, Verstegen MJ, Teunissen H, Splinter E, Wijchers PJ, Krijger PH, de Laat W . CTCF binding polarity determines chromatin looping. Mol Cell, 2015,60(4):676-684. | |||
| [12] | Ong CT, Corces VG . CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet, 2014,15(4):234-246. | |||
| [13] | Huang H, Wu Q . CRISPR double cutting through the labyrinthine architecture of 3D genomes. J Genet Genomics, 2016,43(5):273-288. | |||
| [14] | Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV, Ren B . Analysis of the vertebrate insulator protein CTCF-b
Options
/
|